Evidence map›Paper›PMID 39905859›Full record

ArticleFuture science OA2025

Primary adenocarcinoma of duodenal bulb mimicking a pancreatic tumor: a case report.

Eya Slama, S Ben Hamida, S Zaouga, H Elloumi, I Cheikh, A G Dahak, M Missaoui, A Chelibi, I Ganzoui

Abstract read
In one paragraph

Article in Future science OA, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Eya SlamaDepartement of Gastroenterology, Habib Bougatfa Hospital, Bizerte, Tunisia.
S Ben HamidaDepartement of Gastroenterology, Habib Bougatfa Hospital, Bizerte, Tunisia.
S ZaougaDepartement of Gastroenterology, Habib Bougatfa Hospital, Bizerte, Tunisia.
H ElloumiDepartement of Gastroenterology, Habib Bougatfa Hospital, Bizerte, Tunisia.
I CheikhDepartement of Gastroenterology, Habib Bougatfa Hospital, Bizerte, Tunisia.
A G DahakDepartement of Radiology, Habib Bougatfa Hospital, Bizerte, Tunisia.
M MissaouiDepartement of Radiology, Habib Bougatfa Hospital, Bizerte, Tunisia.
A ChelibiDepartement of Radiology, Habib Bougatfa Hospital, Bizerte, Tunisia.
I GanzouiDepartement of Radiology, Habib Bougatfa Hospital, Bizerte, Tunisia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Duodenal bulb adenocarcinoma is a rare malignancy of the gastrointestinal tract. This cancer often presents with an insidious onset, making it challenging to diagnose early. A noteworthy case-study involved a 56 year-old-woman complaining from epigastric transfixing pain, jaundice, and overall health decline. The initial diagnosis suspected was a pancreatic tumor. An abdominal CT scan however showed no abnormality in the pancreas but revealed on the other hand an irregular, non-stenosing, heterogeneous fibrous thickening of the lower aspect of the duodenal bulb. An EGD showed a congested infiltrated area in the post-bulbar region, and Pathological exam confirmed the diagnosis of a primary adenocarcinoma of the duodenal bulb. The purpose of this article is to present the case of a primary adenocarcinoma of duodenal bulb mimicking a pancreatic tumor: a rare presentation of a rare tumor itself and to present points differentiating these two neoplasms. Diagnosis relies on a comprehensive assessment involving clinical, radiological, endoscopic, and histologic features. Integration of advanced imaging modalities, such as CT/MRI, coupled with upper gastrointestinal endoscopy, is crucial for accurate evaluation.

Indexed as

bulbchemotherapyduodenalduodeno-pancreatectomyPrimary adenocarcinoma

Identifiers

PMID39905859
PMCPMC11801341

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.